Tower Research Capital LLC (TRC) - EDGE THERAPEUTICS INC ownership

EDGE THERAPEUTICS INC's ticker is EDGE and the CUSIP is 279870109. A total of 38 filers reported holding EDGE THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of EDGE THERAPEUTICS INC
ValueSharesWeighting
Q2 2018$3,000
-90.3%
2,567
-24.2%
0.00%
-100.0%
Q4 2017$31,000
-3.1%
3,385
+15.6%
0.00%
+33.3%
Q3 2017$32,000
+166.7%
2,928
+145.8%
0.00%
+200.0%
Q2 2017$12,000
+1100.0%
1,191
+1732.3%
0.00%
Q4 2016$1,000
-95.2%
65
-96.7%
0.00%
-100.0%
Q3 2016$21,000
+250.0%
1,973
+286.9%
0.00%
+100.0%
Q4 2015$6,0005100.00%
Other shareholders
EDGE THERAPEUTICS INC shareholders Q3 2018
NameSharesValueWeighting ↓
New Leaf Venture Partners, L.L.C. 2,344,868$24,058,00016.90%
VHCP Management II, LLC 1,933,582$19,839,0007.92%
ACUTA CAPITAL PARTNERS, LLC 1,504,612$15,437,0004.32%
Opaleye Management Inc. 130,000$1,334,0000.56%
SPHERA FUNDS MANAGEMENT LTD. 150,000$1,539,0000.26%
DAFNA Capital Management LLC 19,400$199,0000.14%
REGENTATLANTIC CAPITAL LLC 134,900$1,384,0000.13%
MARK SHEPTOFF FINANCIAL PLANNING, LLC 14,400$148,0000.10%
TFS CAPITAL LLC 20,080$206,0000.08%
EAGLE ASSET MANAGEMENT INC 901,359$9,247,0000.06%
View complete list of EDGE THERAPEUTICS INC shareholders